title: Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens.
abstract: The molecular and cellular processes that induce rapid atherosclerotic plaque progression in patients with unstable angina and initiate restenosis following coronary interventional procedures are uncertain. We examined primary (de novo) and restenotic lesions retrieved at the time of directional coronary atherectomy for expression of insulin-like-growth factor-I (IGF-I). IGF-I receptor, and five IGF binding proteins (IGFBPs), IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, and IGFBP-5 in smooth muscle cells (SMCs) using colloidal gold immunocytochemistry. IGF-1, its receptor and binding proteins were not detected in SMCs of normal coronary arteries. IGF-I localized primarily in synthetic smooth muscle cells (sSMCs) in both de novo and restenotic plaques. IGF-I receptor localized on sSMCs and their processes and colocalized with IGF-I. Although morphometric analysis of IGF-I and IGF-I receptor immunoreactivity in sSMCs of de novo and restenotic lesions showed comparable levels of IGF-I (3.2 +/- 1.0 and 2.9 +/- 0.9, respectively). IGF-I receptor was significantly higher in de novo lesions as compared to restenotic lesions (10.7 +/- 2.5 and 4.2 +/- 1.3, P < 0.05, respectively). IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4 and IGFBP-5 localized in the cytoplasm of sSMCs and in the extracellular matrix. Quantitative reverse transcription polymerase chain reaction (QRT-PCR) performed on de novo atherectomy specimens identified mRNA for IGF-I, IGF-I receptor, IGFBP-1, IGFBP-2, IGFBP-4, IGFBP-5 levels and detected mRNA for IGFBP-3. The expression of IGF-I, IGF-I receptor, and IGFBPs in atherectomy plaques suggests that the development of coronary obstructive lesions may be a result of changes in the IGF system.
authors.affiliation: Department of Medicine, College of Medicine, University of Florida, Gainesville 32610-0226, USA.
authors.forename: M B
authors.initials: MB
authors.lastname: Grant
authors.forename: T J
authors.initials: TJ
authors.lastname: Wargovich
authors.forename: E A
authors.initials: EA
authors.lastname: Ellis
authors.forename: R
authors.initials: R
authors.lastname: Tarnuzzer
authors.forename: S
authors.initials: S
authors.lastname: Caballero
authors.forename: K
authors.initials: K
authors.lastname: Estes
authors.forename: M
authors.initials: M
authors.lastname: Rossing
authors.forename: P E
authors.initials: PE
authors.lastname: Spoerri
authors.forename: C
authors.initials: C
authors.lastname: Pepine
mesh_terms: D017225:Atherectomy, Coronary; D003324:Coronary Artery Disease / Q000378:metabolism; D003331:Coronary Vessels / Q000737:chemistry / Q000378:metabolism; D004587:Electrophoresis, Agar Gel; D005786:Gene Expression Regulation / Q000235:genetics; D017979:Gold Colloid / Q000276:immunology; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D016253:Microscopy, Immunoelectron; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000378:metabolism*
chemical_list: D017979:Gold Colloid; D018969:Insulin-Like Growth Factor Binding Proteins; D012333:RNA, Messenger; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1